Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDTY.L Regulatory News (DTY)

  • There is currently no data for DTY

Directorate Changes

23 Apr 2021 17:43

RNS Number : 5048W
Dignity PLC
23 April 2021
 

23 April 2021

Dignity plc

("Dignity" or the "Company")

Directorate Changes

Dignity plc, the UK's only listed provider of funeral related services, announces the following directorate changes following the General Meeting held yesterday.

 

Clive Whiley has ceased to be a Director of the Company and Gary Channon has been appointed as Executive Chairman, in each case with immediate effect. The Independent Non-Executive Directors, comprising Gillian Kent, Dean Moore and Paul Humphreys, have resigned from the Board, in the case of Gillian Kent and Paul Humphreys, with immediate effect. Dean Moore, given his current role as Interim Chief Financial Officer, will continue to serve as a director for his three-month notice period to enable an orderly transition.

 

Commenting on the changes, Gary Channon, Executive Chairman of Dignity plc, said:

 

"We are pleased that the resolutions proposed have been passed at the General Meeting held yesterday.

As we have said all along, we will now commence a process to appoint new Independent Non-Executive Directors including a Non-Executive Chairman. This will result in a new Board with a majority of Independent Directors.

 

We believe Dignity to be a good business with great potential, and as a Board are now focused on the future. We are very excited to unlock this value for the benefit of all shareholders, clients, employees and our wider stakeholders and look forward to engaging with all of these groups as we embark on delivering the strategy and vision for Dignity. Work is already underway and we will update shareholders in due course."

 

Gary Channon

Executive Chairman

 

This announcement is made pursuant to Listing Rule 9.6.11R.

 

Pursuant to Listing Rule 9.6.13, in 1996 whilst an employee at an international investment bank, Gary Channon was involved in a proprietary trading scheme which breached Australian securities laws and resulted in disciplinary proceedings and a fine being imposed on Mr Channon and a more senior employee, by the SFA. However, the SFA held that Mr Channon did not know or believe that the scheme was unlawful, and he at all times has retained his status as fit and proper.

 

There are no other details required to be disclosed under Listing Rule 9.6.13R.

 

 

For further information please contact:

Buchanan +44 (0)20 7466 5000

Richard Oldworth

Chris Lane

Tilly Abraham

www.buchanan.uk.com dignity@buchanan.uk.com

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAIJMFTMTITBBB
Date   Source Headline
17th Oct 202211:05 amRNSNotification of Major Holdings
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSInterim Results
29th Sep 202211:31 amRNSResults of Consent Solicitation with Bondholders
15th Sep 20228:37 amRNSChange in Director’s Particulars
15th Sep 20227:00 amRNSUpdate to release date of 2022 Half-Year Results
7th Sep 20223:55 pmRNSConsent solicitation with Noteholders
31st Aug 20228:55 amRNSVoting Rights and Capital
29th Jul 202210:01 amRNSVoting Rights and Capital
29th Jul 20227:46 amRNSFCA Regulation
20th Jul 20229:00 amRNSDignity Announces Aim to be Net Zero By 2038
30th Jun 20224:50 pmRNSVoting Rights and Capital
17th Jun 20227:25 amRNS“intending to authorise” status from the FCA
14th Jun 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
9th Jun 20223:12 pmRNSBoard Update
9th Jun 202212:54 pmRNSResults of AGM
6th Jun 20227:00 amRNSNotification of Major Holdings
31st May 20227:00 amRNSVoting Rights and Capital
27th May 20222:52 pmRNSChange in Director’s Particulars
16th May 20227:00 amRNSAppointment of Chief Executive Officer
11th May 20227:00 amRNSFirst Quarter Trading Update
3rd May 202210:41 amRNSNotification of Major Holdings
29th Apr 20228:04 amRNS2021 Annual Report & Notice of 2022 AGM
29th Apr 20227:00 amRNSVoting Rights and Capital
14th Apr 202210:24 amRNSBLOCK LISTING SIX MONTHLY RETURN
4th Apr 202210:59 amRNSDirectorate Change
31st Mar 20227:00 amRNSTotal Voting Rights
30th Mar 202212:34 pmRNSNotification of Major Holdings
23rd Mar 20227:00 amRNSPreliminary Results
11th Mar 202211:49 amRNSResults of Bondholders Consent Solicitation
2nd Mar 20224:40 pmRNSSecond Price Monitoring Extn
2nd Mar 20224:35 pmRNSPrice Monitoring Extension
28th Feb 20227:00 amRNSVoting Rights and Capital
17th Feb 202210:30 amRNSTrading Update & Consent solicitation period
14th Feb 20227:00 amRNSNotification of Preliminary Results
12th Jan 202212:57 pmRNSBoard Appointment
7th Jan 20223:30 pmRNSBoard Appointments
31st Dec 20217:00 amRNSVoting Rights and Capital
17th Dec 20218:49 amRNSDirector Dealing Notification
14th Dec 202110:16 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Nov 20217:00 amRNSVoting Rights and Capital
8th Nov 20217:00 amRNSQ3 Trading Update
21st Oct 20217:00 amRNSAppointment of Joint Broker
14th Oct 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
30th Sep 20217:00 amRNSVoting Rights and Capital
21st Sep 20217:00 amRNSInterim Results
1st Sep 20217:00 amRNSBoard Appointment
26th Jul 20217:00 amRNSBoard Appointment
12th Jul 20217:00 amRNSUpdate to release date of 2021 Half-Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.